210 related articles for article (PubMed ID: 11805297)
1. Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3 beta but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of tau: implications for Alzheimer's disease.
Papasozomenos SCh; Shanavas A
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1140-5. PubMed ID: 11805297
[TBL] [Abstract][Full Text] [Related]
2. tau kinases in the rat heat shock model: possible implications for Alzheimer disease.
Shanavas A; Papasozomenos SC
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14139-44. PubMed ID: 11121021
[TBL] [Abstract][Full Text] [Related]
3. The heat shock-induced hyperphosphorylation of tau is estrogen-independent and prevented by androgens: implications for Alzheimer disease.
Papasozomenos SC
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6612-7. PubMed ID: 9192613
[TBL] [Abstract][Full Text] [Related]
4. The activation of heat shock transcription factor 1 is differentially regulated in the brain of estrogen- and testosterone-treated heat-shocked rats.
Papasozomenos SCh; Papasozomenos H
J Alzheimers Dis; 2008 Nov; 15(3):375-90. PubMed ID: 18997291
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
Lovestone S; Reynolds CH; Latimer D; Davis DR; Anderton BH; Gallo JM; Hanger D; Mulot S; Marquardt B; Stabel S
Curr Biol; 1994 Dec; 4(12):1077-86. PubMed ID: 7704571
[TBL] [Abstract][Full Text] [Related]
6. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
Leclerc S; Garnier M; Hoessel R; Marko D; Bibb JA; Snyder GL; Greengard P; Biernat J; Wu YZ; Mandelkow EM; Eisenbrand G; Meijer L
J Biol Chem; 2001 Jan; 276(1):251-60. PubMed ID: 11013232
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta.
Reynolds CH; Betts JC; Blackstock WP; Nebreda AR; Anderton BH
J Neurochem; 2000 Apr; 74(4):1587-95. PubMed ID: 10737616
[TBL] [Abstract][Full Text] [Related]
8. Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain.
Bennecib M; Gong CX; Grundke-Iqbal I; Iqbal K
FEBS Lett; 2000 Nov; 485(1):87-93. PubMed ID: 11086171
[TBL] [Abstract][Full Text] [Related]
9. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.
Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ
J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188
[TBL] [Abstract][Full Text] [Related]
10. Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase.
Mudher A; Chapman S; Richardson J; Asuni A; Gibb G; Pollard C; Killick R; Iqbal T; Raymond L; Varndell I; Sheppard P; Makoff A; Gower E; Soden PE; Lewis P; Murphy M; Golde TE; Rupniak HT; Anderton BH; Lovestone S
J Neurosci; 2001 Jul; 21(14):4987-95. PubMed ID: 11438574
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of MAP kinase by v-raf transformation of fibroblasts fails to induce hyperphosphorylation of transfected tau.
Latimer DA; Gallo JM; Lovestone S; Miller CC; Reynolds CH; Marquardt B; Stabel S; Woodgett JR; Anderton BH
FEBS Lett; 1995 May; 365(1):42-6. PubMed ID: 7774712
[TBL] [Abstract][Full Text] [Related]
12. Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain.
Liu SJ; Zhang JY; Li HL; Fang ZY; Wang Q; Deng HM; Gong CX; Grundke-Iqbal I; Iqbal K; Wang JZ
J Biol Chem; 2004 Nov; 279(48):50078-88. PubMed ID: 15375165
[TBL] [Abstract][Full Text] [Related]
13. Tau therapeutic strategies for the treatment of Alzheimer's disease.
Churcher I
Curr Top Med Chem; 2006; 6(6):579-95. PubMed ID: 16712493
[TBL] [Abstract][Full Text] [Related]
14. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5.
Sengupta A; Wu Q; Grundke-Iqbal I; Iqbal K; Singh TJ
Mol Cell Biochem; 1997 Feb; 167(1-2):99-105. PubMed ID: 9059986
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse.
Planel E; Yasutake K; Fujita SC; Ishiguro K
J Biol Chem; 2001 Sep; 276(36):34298-306. PubMed ID: 11441005
[TBL] [Abstract][Full Text] [Related]
17. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II.
Yamaguchi H; Ishiguro K; Uchida T; Takashima A; Lemere CA; Imahori K
Acta Neuropathol; 1996 Sep; 92(3):232-41. PubMed ID: 8870824
[TBL] [Abstract][Full Text] [Related]
18. Site-specific phosphorylation of tau accompanied by activation of mitogen-activated protein kinase (MAPK) in brains of Niemann-Pick type C mice.
Sawamura N; Gong JS; Garver WS; Heidenreich RA; Ninomiya H; Ohno K; Yanagisawa K; Michikawa M
J Biol Chem; 2001 Mar; 276(13):10314-9. PubMed ID: 11152466
[TBL] [Abstract][Full Text] [Related]
19. Facilitation of sexual behavior in ovariectomized rats by estradiol and testosterone: A preclinical model of androgen effects on female sexual desire.
Jones SL; Ismail N; Pfaus JG
Psychoneuroendocrinology; 2017 May; 79():122-133. PubMed ID: 28278441
[TBL] [Abstract][Full Text] [Related]
20. Sites of phosphorylation in tau and factors affecting their regulation.
Anderton BH; Betts J; Blackstock WP; Brion JP; Chapman S; Connell J; Dayanandan R; Gallo JM; Gibb G; Hanger DP; Hutton M; Kardalinou E; Leroy K; Lovestone S; Mack T; Reynolds CH; Van Slegtenhorst M
Biochem Soc Symp; 2001; (67):73-80. PubMed ID: 11447841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
